Accuracy of Detection and Grading of Diabetic Retinopathy and Diabetic Macular Edema Using Teleretinal Screening

被引:23
|
作者
Date, Rishabh C. [1 ,2 ]
Shen, Kevin L. [3 ]
Shah, Beena M. [3 ]
Sigalos-Rivera, Mara A. [3 ]
Chu, Yvonne, I [1 ,2 ]
Weng, Christina Y. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Ophthalmol, Houston, TX USA
[2] Ben Taub Gen Hosp, Dept Ophthalmol, Harris Hlth Syst, Houston, TX USA
[3] Baylor Coll Med, Sch Med, Houston, TX USA
来源
OPHTHALMOLOGY RETINA | 2019年 / 3卷 / 04期
关键词
D O I
10.1016/j.oret.2018.12.003
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine the accuracy of a county teleretinal screening program of detecting referable diabetic retinopathy (DR) and treatable diabetic macular edema (DME), as well as to evaluate patient compliance with clinic follow-up after referral from teleretinal screening. Design: Retrospective observational study. Participants: Patients in the Harris Health System (HHS, Houston, TX) older than 18 years of age who underwent teleretinal screening between July 2014 and July 2016. Methods: Teleretinal imaging (TRI) consisting of single-field 45-degree nonmydriatic color fundus photography with referral thresholds of severe nonproliferative DR, proliferative DR, and significant DME. Teleretinal imaging results for all referred subjects were obtained and cross-referenced with dilated fundus examination findings with regard to DR severity and the presence of DME. Follow-up status was also noted. Subjects underwent OCT if deemed necessary by the examining specialist. Agreement between TRI and dilated fundus examination (DFE) findings was determined by calculating the Cohen k coefficient. Main Outcome Measures: The primary outcome measure is agreement between TRI results and DFE findings with regard to DR severity and the presence of DME. The secondary outcome measure is compliance with follow-up. Results: Of 1767 patients who were screened and referred for clinical examination, 935 (52.9%) attended their clinic appointment. Overall agreement between DFE and TRI was moderate (weighted k 0.45) in terms of DR severity. There was agreement within one DR severity level in 86.2% of patients. The positive predictive value for detecting referable disease was 71.3%. Of patients referred for DME, 30.4% were deemed to have treatable DME. Conclusions: The HHS teleretinal screening program demonstrates a high level of accuracy in the detection and classification of referable DR, but a lesser degree of accuracy in the detection of treatable DME. Only slightly more than half of participants were compliant with follow-up after a TRI referral. This large-scale study provides insight into the utility of teleretinal screening in a county health care system. (C) 2018 by the American Academy of Ophthalmology.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 50 条
  • [21] Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy
    Walton, O. Bennett
    Garoon, Robert B.
    Weng, Christina Y.
    Gross, Jacob
    Young, Alex K.
    Camero, Kathryn A.
    Jin, Haoxing
    Carvounis, Petros E.
    Coffee, Robert E.
    Chu, Yvonne I.
    JAMA OPHTHALMOLOGY, 2016, 134 (02) : 204 - 209
  • [22] Optimized deep CNN for detection and classification of diabetic retinopathy and diabetic macular edema
    Thanikachalam, V
    Kabilan, K.
    Erramchetty, Sudheer Kumar
    BMC MEDICAL IMAGING, 2024, 24 (01):
  • [23] Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy
    Changyow C. Kwan
    Amani A. Fawzi
    Current Diabetes Reports, 2019, 19
  • [24] Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema
    Bearse, Marcus A., Jr.
    Ozawa, Glen Y.
    CURRENT DIABETES REPORTS, 2015, 15 (09)
  • [25] Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
    Jie Ding
    Tien Yin Wong
    Current Diabetes Reports, 2012, 12 : 346 - 354
  • [26] Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
    Rechtman, Ehud
    Harris, Alon
    Garzozi, Hanna J.
    Ciulla, Thomas A.
    CLINICAL OPHTHALMOLOGY, 2007, 1 (04): : 383 - 391
  • [27] Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema
    Marcus A. Bearse
    Glen Y. Ozawa
    Current Diabetes Reports, 2014, 14
  • [28] Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema
    Antoszyk, Andrew N.
    Tarnowski, Kathleen Wade
    Basu, Karen
    Ehrlich, Jason S.
    Haskova, Zdenka
    OPHTHALMOLOGY RETINA, 2020, 4 (10): : 1034 - 1036
  • [29] Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy
    Kwan, Changyow C.
    Fawzi, Amani A.
    CURRENT DIABETES REPORTS, 2019, 19 (10)
  • [30] Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema
    Diaz-Llopis, Manuel
    Udaondo, Patricia
    Maria Millan, Jose
    Fernando Arevalo, J.
    WORLD JOURNAL OF DIABETES, 2013, 4 (06) : 319 - 323